- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 13
9000 Gent - Peter.Hellings@UGent.be
Show
Sort by
-
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds
-
International consensus statement on allergy and rhinology : rhinosinusitis 2021
-
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial
-
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management
-
Surgery in nasal polyp patients : outcome after a minimum observation of 10 years
-
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review